Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0625_j.ccell.2020.05.019

Targeting the PP2A-STRN3 interaction to treat gastric cancer

Aug 27, 2020 | 9:22 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Gastric cancer

Interrupting the interaction between PP2A

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE